The Design of Profitable Biotechnology Structures raises a number of questions. Konstantinos Stratakis and a panel of distinguished guests are called to answer these very questions during the 2nd Conference on Synergy Structures in Health Care, Biotechnology and Economics.
How can we set up an industrial structure aimed at developing drugs and medical equipment in the health sector?
How can we build a profitable production structure through the development of specific technologies in Greece? Are there any examples in Greece or in countries like Greece with a similar socio-economic profile?
Which is the growth strategy of a healthcare company?
What are the points that one should take into account at a legal level when planning a business in the health-biotechnology sector?
Notable excerpts from the discussion:
- We need an ecosystem where innovation, research, private and public sectors can work together.
- Greece has access to significant resources, becoming competitive across Europe as well.
- We are falling short in mentality by principle. We don’t have a – much needed – state infrastructure. We have no medical records yet. We have no uniform policy on DATA, we have no technology transfer bureaus in our universities.
- The environment is changing, and we also just came out of the economic crisis.
- Our human resources are well equipped, we have inspiring people who have the will, the drive and the resources.
- I have started investing in Greek start-ups since 2009, and I can tell you that the style and ethos of entrepreneurs has changed a lot since then.
- Money exists in Greece only for startups. What you emphasized is the extroversion in the effort to get funding, and especially access to the American market.
You can find all answers to these key questions and the statements of Konstantinos Stratakis (Director of Human Genetics and Personalised Medicine at the Institute of Molecular Biology at FORTH) and interlocutors in Komvos-Node’s YouTube channel.
Participants in the discussion:
- George Kaliviotis (Vice President and Head of Product Supply, FUJIFILM Diosynth Biotechnologies, USA),
- Ioanna Michalopoulou (Managing Partner – Life Sciences and Medical Technology Attorney at Law, Greece),
- Lina Nikolopoulou (Managing Director, MINDVIEW Strategy & Research, Greece) and,
- George Papadopoulos (Angel Investor).
The workshop was organized by Komvos-Node in collaboration with the ARISTEiA Institute USA due to the Bio³ conference organized by Bioinnovation.
Moderators of the workshop: Konstantinos Drosatos (University of Cincinnati, USA, President of ARISTEiA and Secretary General of the Board of Directors of Komvos-Node) and Nikos Kyrpides (Berkeley National Laboratory, USA and Member of the Board of Directors of Komvos-Node).
The seminar is sponsored by the pharmaceutical company DEMO ABEE.
Komvos-Node’s supporter is the accounting and consulting firm Ecovis-Onetax.
Komvos-Node’s Major Sponsor is Piraeus Bank, which supports it in the realization of its vision.
